Vertex Pharmaceuticals stock falls after pain drug fails in Phase 2 study
Avalon Holdings Corporation (NYSE American:AWX), a small-cap company with a market value of $9.59 million, announced the results of its Annual Meeting of Stockholders held on May 7, 2025, according to an 8-K filing with the Securities and Exchange Commission. InvestingPro analysis indicates the stock is trading below its Fair Value, with attractive multiples including a price-to-book ratio of 0.28. During the meeting, shareholders voted on the election of directors and an advisory vote on executive compensation.
The holders of Class B Common Stock elected four directors: Ronald E. Klingle, Michael J. Havalo, Timothy C. Coxson, and Christine M. Bell. Each director received 6,111,330 votes in favor, with no votes withheld or abstentions and no broker non-votes recorded.
The Class A Common Stock shareholders elected two directors, Kurtis D. Gramley and Stephen L. Gordon. Gramley received 450,136 votes for, 1,462,275 votes withheld, and 1,363,103 broker non-votes. Gordon garnered 440,096 votes for, 1,472,315 votes withheld, and 1,363,103 broker non-votes.
Additionally, the non-binding advisory vote on the compensation of the company’s named executive officers passed with 6,635,136 votes for, 1,376,949 against, 11,656 abstentions, and 1,363,103 broker non-votes.
The filing confirms that all matters presented at the meeting were duly voted upon, with the results indicating shareholder approval for the company’s executive compensation and the election of the nominated directors. The 8-K report does not include any further details on the proceedings or resolutions passed during the meeting. The company has maintained profitability over the last twelve months, with a return on equity of 4%. Investors anticipating Avalon’s next earnings report on May 9, 2025, can access additional insights and financial metrics through InvestingPro, which offers exclusive analysis and 6 key investment tips for AWX stock.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.